InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: biopharm post# 277744

Tuesday, 11/01/2016 11:36:01 PM

Tuesday, November 01, 2016 11:36:01 PM

Post# of 345749


Peregrine Pharmaceuticals Sunrise study, now evaluating how many proteins? I'd say most of them are on slide#40 from the above link

and notice the bottom of slide #40

Over 100 potential checkpoint proteins
AGENUS HAS ADDITIONAL UNDISCLOSED CPM PROGRAMS


I say someone trying to covertly cover up.... PS Targeting and it is not going to just slip by this landscaper

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News